Ascending Multiple Intravenous Doses of AON-D21 in Healthy Male Subjects.
Clinical trial NCT05343819 · COMPLETED
Trial details
- NCT number
- NCT05343819
- Sponsor
- Aptarion Biotech AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-12
- Primary completion
- 2022-11-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.